John Tesh was diagnosed with prostate cancer despite having a low PSA and given 18 months to live back in 2015. Now, 10 years ...

Mass population testing for prostate cancer will not see men proactively invited for the PSA blood test - here is all you ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...

The NHS does not offer routine prostate cancer screening for all men. The PSA (prostate-specific antigen) test, which ...

For decades, it has been known that prostate specific antigen ‒ or PSA ‒ tests are a flawed way to diagnose prostate cancer. Many men have a high PSA without having cancer. Others have low PSA that ...

The accuracy of prostate-specific antigen (PSA) screening can be improved by accounting for genetic factors that cause changes in PSA levels that are not associated with cancer, according to a ...

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

Prostate cancer is much more likely to kill if a man's PSA level rises rapidly before the cancer is even diagnosed, according to a study that suggests a new and far more meaningful way of looking at ...

Please provide your email address to receive an email when new articles are posted on . At any given PSA level, Black men are more likely than white men to harbor prostate cancer, according to ...

Declines in prostate-specific antigen (PSA) level after treatment with the next-generation androgen receptor inhibitor drug enzalutamide predict improved survival rates in men with non-metastatic ...